Electronic health records for dementia care research in 2026 mean researchers review your digital medical history to find risk patterns and invite the right people to studies. Adults with memory concerns can use specific participation questions to decide whether to join. An electronic health record is the digital file your clinic keeps on visits, diagnoses, drugs, and test results. Research teams now analyze those files to predict Alzheimer's or related dementia and to map illness paths before symptoms appear.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How are health records used in dementia research now?
- What should you ask before you agree?
- Who can join and what does it involve?
- Where can you find a study near you?
- What are the limits of record-based detection?
- Frequently Asked Questions
How are health records used in dementia research now?
The USC Schaeffer Center developed a Passive Digital Marker that analyzes electronic health records to predict Alzheimer's or related dementia within 1 to 3 years with 80% accuracy. The tool is now being tested in 12 Indiana University Health primary-care clinics with text-message follow-up, according to the USC pilot description.
Columbia University's M3AD Study and Real-World Data Metaplatform harmonized records from nearly 10 million patients across New York, Chicago and Miami, including about 60,000 with Alzheimer's disease and related dementias. The Columbia Mailman School of Public Health reports the platform maps multimorbidity trajectories preceding dementia, as described in the Columbia data platform announcement. The M3AD design paper frames the platform as a tool to improve risk prediction, guide complex clinical management, and evaluate future treatments in real-world settings.
What should you ask before you agree?
The National Institute on Aging advises adults with memory concerns who find a study to contact the listed research staff and ask direct questions. Those questions cover purpose, risks and benefits, placebo use, visit frequency, duration, and costs.
Bring this checklist to the call: Clear answers help you compare studies and protect daily care. Write down names, dates, and next steps.
- Will I receive placebo or active treatment, and how often must I visit?
- How long does the study last and what will it cost me?
- Can I keep taking my regular medications during the study?
- How will the team keep my own doctor informed?
Who can join and what does it involve?
Participation in Alzheimer's and related-dementias research is voluntary with informed consent and the right to withdraw, according to MyBrainGuide citing NIA guidance. Many trials require a caregiver or study partner for support and reporting. Eligibility screening may involve questionnaires, health assessments or in-person visits.
A partner often attends visits, reports changes in memory or function, and helps track drugs and side effects. Ask whether the study needs a study partner, who can serve in that role, and what happens if you withdraw. Voluntary means you can leave at any time without losing regular medical care.
Where can you find a study near you?
People with dementia or memory problems, caregivers, and healthy volunteers can search the Alzheimers.gov Clinical Trials Finder for nearby studies. You can also contact an NIA-funded Alzheimer's Disease Research Center for diagnosis, support-group and trial information. Have your medication list, diagnosis history, and location ready before you search.
Call the listed research staff directly if online forms are confusing. Centers can explain referral needs, travel demands, and whether record-based prescreening applies. That call saves time for both you and the study team.
What are the limits of record-based detection?
Health records are incomplete and coded inconsistently across systems. Record-based detection can miss undetected dementia, and prediction models still require clinical confirmation before care or enrollment decisions.
The FDA tells sponsors and investigators to verify record completeness and accuracy, account for format differences across systems, and document data retrieval and transformation, according to the FDA guidance on EHR data in clinical investigations. Ask how the team confirmed your eligibility beyond the computer flag.
Frequently Asked Questions
Will a health-record flag mean I have dementia?
No. It signals higher predicted risk or possible eligibility. A clinician must confirm with exams and tests before diagnosis or enrollment.
Do I need a caregiver to join?
Many Alzheimer's trials do. Ask the study staff whether a study partner is required and what tasks that person will do.
You Might Also Like
- CMS GUIDE and Other Dementia Care Models Under Review in 2026: What Comes Next and What Family Caregivers Should Watch
- Unpaid Dementia Care Costs in the 2026 NIA Summit Report: Cost and Access Questions for Working Dementia Caregivers
- How to Discuss PSEN2 Genetic Test Results For Younger Adults With Memory Problems
